🕒 Created

James Comer Leads House Oversight Committee Investigation into DEA Fentanyl Policies

The House Oversight Committee has opened an investigation into the U.S. Drug Enforcement Administration’s strategy of allowing significant quantities of fentanyl to reach American streets while agents build larger narcotics cases. Representative James Comer, the committee chair, sent a letter to the U.S. Department of Justice seeking internal records regarding the practice, which is often referred to as "fentanyl walking." Whistleblowers within the DEA disclosed that agents were directed to stand down and let hundreds of thousands of pills pass through New Mexico between 2023 and 2025 to identify high-level traffickers. This practice occurred during the most severe drug epidemic in U.S. history, despite the DEA's "One Pill Can Kill" campaign. Representative James Comer noted that the Biden administration relaxed safety protocols established during President Trump's first term, which originally instructed law enforcement to seize fentanyl as soon as practicable. The Justice Department updated these guidelines in 2024 to allow officers more latitude to delay seizures. New Mexico Attorney General RaĂșl Torrez filed a lawsuit against the Justice Department demanding access to these records, alleging that the state experienced a 21 percent rise in overdose deaths while national overdose deaths declined. The committee set a September 14 deadline for the Justice Department to provide the requested information.

Sources

Paywall and unreadable sources